Companies / Neurocrine Biosciences Inc
Neurocrine Biosciences Inc
Insider flow · last 90 daysNet sells $41.96M
Financials · FY2025
Ownership
101.6M shares outstanding · as of Jul 22, 2026
Ownership
| Insiders | 0.47% | 478,379 |
| 10%+ / strategic | 5.11% | 5,198,084 |
| Institutions | 97.67% | 99,285,537 |
| Public float | 0.00% | 0 |
Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 18
View all →| Insider | % of shares | Shares |
|---|---|---|
Gorman Kevin CharlesFormerDirector | 0.50% | 511,293 |
Gano KyleCEOChief Executive Officer · Director | 0.15% | 150,815 |
Lyons Gary aDirector | 0.12% | 122,141 |
Benevich EricChief Commercial Officer | 0.06% | 63,190 |
Lippoldt DarinFormerChief Legal Officer | 0.05% | 54,729 |
Rastetter William HDirector | 0.04% | 43,678 |
Abernethy MattFormerChief Financial Officer | 0.04% | 42,808 |
Pops Richard FDirector | 0.04% | 37,798 |
Cooke JulieFormerChief Human Resources Officer | 0.03% | 34,170 |
Onyia JudeChief Scientific Officer | 0.03% | 25,670 |
Institutional holders 735
View all →| Holder | Value | % of shares |
|---|---|---|
| $2.31B | 13.49% | |
| $1.38B | 9.54% | |
| $781.21M | 5.42% | |
| $739.13M | 4.31% | |
| $737.57M | 5.12% | |
| $650.66M | 4.86% | |
| $403.20M | 3.01% | |
| $318.67M | 2.38% | |
| $280.80M | 2.10% | |
| $247.43M | 1.72% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Two Sigma Investments, LP 13F manager | Add | Common stock | $273.46M | +2.1M +210.78% | 3,060,570 3.01% of shares | high |
| Q1 2026 as of | AQR Capital Management, LLC 13F manager | Add | Common stock | $219.64M | +1.7M +50.96% | 4,938,967 4.86% of shares | high |
| Q1 2026 as of | Norges Bank 13F manager | Exit | Common stock | $-162.66M | -1.1M -100.00% | 0 | high |
| Q1 2026 as of | Los Angeles Capital Management LLC 13F manager | Trim | Common stock | $-150.47M | -1.1M -88.45% | 149,111 0.15% of shares | high |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common stock | $148.48M | +881K +6.87% | 13,711,607 13.49% of shares | high |
| Q1 2026 as of | Millennium Management LLC 13F manager | Add | Common stock | $106.00M | +805K +181.68% | 1,247,447 1.23% of shares | high |
| Q1 2026 as of | Victory Capital Management, Inc. 13F manager | Add | Common stock | $79.97M | +607K +487.35% | 731,609 0.72% of shares | high |
| Q1 2026 as of | Deerfield Management Company, L.P. 13F manager | Trim | Common stock | $-75.66M | -574K -48.49% | 610,000 0.60% of shares | high |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| JPMorgan Chase & Co | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| NBIX | — | 64125C109 |